Lv5
1020 积分 2024-01-26 加入
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
17天前
已完结
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
19天前
已完结
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
25天前
已完结
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
25天前
已完结
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
1个月前
已完结
An overview of CCN4 (WISP1) role in human diseases
1个月前
已完结
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial
1个月前
已完结
Meaningful changes for efficacy outcomes in patients with chronic rhinosinusitis with nasal polyps
2个月前
已完结
Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study
3个月前
已完结
CAR-T Cells For Treating Systemic Lupus Erythematosus: A Promising Emerging Therapy
4个月前
已完结
皖公网安备34019202002308
